Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Dialyzer Market, by Type
1.4.2 Europe Dialyzer Market, by End User
1.4.3 Europe Dialyzer Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Dialyzer Market by Type
3.1 Europe High-Flux Dialyzer Market by Country
3.2 Europe Low-Flux Dialyzer Market by Country
Chapter 4. Europe Dialyzer Market by End User
4.1 Europe In-Center Dialysis Market by Country
4.2 Europe Home Dialysis Market by Country
Chapter 5. Europe Dialyzer Market by Country
5.1 Germany Dialyzer Market
5.1.1 Germany Dialyzer Market by Type
5.1.2 Germany Dialyzer Market by End User
5.2 UK Dialyzer Market
5.2.1 UK Dialyzer Market by Type
5.2.2 UK Dialyzer Market by End User
5.3 France Dialyzer Market
5.3.1 France Dialyzer Market by Type
5.3.2 France Dialyzer Market by End User
5.4 Russia Dialyzer Market
5.4.1 Russia Dialyzer Market by Type
5.4.2 Russia Dialyzer Market by End User
5.5 Spain Dialyzer Market
5.5.1 Spain Dialyzer Market by Type
5.5.2 Spain Dialyzer Market by End User
5.6 Italy Dialyzer Market
5.6.1 Italy Dialyzer Market by Type
5.6.2 Italy Dialyzer Market by End User
5.7 Rest of Europe Dialyzer Market
5.7.1 Rest of Europe Dialyzer Market by Type
5.7.2 Rest of Europe Dialyzer Market by End User
Chapter 6. Company Profiles
6.1 Baxter International, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Collaborations, partnerships and agreements:
6.1.5.2 Product launches:
6.1.5.3 Expansions:
6.1.5.4 Acquisition and mergers:
6.2 CVS Health Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Recent strategies and developments:
6.2.4.1 Product launches:
6.3 Fresenius Medical Care AG & Co. KGaA
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Collaborations, partnerships and agreements:
6.3.5.2 Expansions:
6.3.5.3 Product launches:
6.3.5.4 Acquisition and mergers:
6.4 DaVita, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Recent strategies and developments:
6.4.4.1 Acquisition and mergers:
6.4.4.2 Product launches:
6.4.4.3 Expansions:
6.5 Asahi Kasei Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.6 Cardinal Health, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.7 Cantel Medical Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Nipro Corporation
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Allmed Medical Care Holdings Limited.
6.9.1 Company overview
6.1 Terumo Corporation
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental Analysis
6.10.4 Recent strategies and developments:
6.10.4.1 Acquisition and mergers:
Unique Offerings 